6533b831fe1ef96bd1299987

RESEARCH PRODUCT

Temporal trends and predictors of inhospital death in patients hospitalised for heart failure in Germany.

Philip WenzelLukas HobohmThomas MünzelStavros KonstantinidesMareike LankeitMareike LankeitKarsten KellerKarsten KellerSebastian GöbelMir Abolfazl Ostad

subject

Heart transplantationHeart FailureMalemedicine.medical_specialtyEpidemiologybusiness.industryIncidence (epidemiology)medicine.medical_treatmentPatient characteristicsComorbiditymedicine.diseaseHospitalizationHeart failureGermanyCase fatality rateEmergency medicineMedicineHumansIn patientFemaleHospital MortalityCardiology and Cardiovascular MedicinebusinessAged

description

Abstract Aims We investigated trends in incidence, case fatality rate, patient characteristics and adverse inhospital events of patients hospitalised for heart failure in Germany. Methods and results The German nationwide inpatient sample (2005–2016) was used for this analysis. Patients hospitalised due to heart failure were selected for analysis. Temporal trends in the incidence of hospitalisations, case fatality rate and treatments were analysed and predictors of inhospital death were identified. The analysis comprised a total number of 4,539,140 hospitalisations (52.0% women, 81.0% aged ≥70 years) due to heart failure. Although hospitalisations increased from 381 (2005) to 539 per 100,000 population (2016) (β estimate 0.06, 95% confidence interval (CI) 0.06 to 0.07, P < 0.001) in parallel with median age and prevalence of comorbidities, the inhospital case fatality rate decreased from 11.1% to 8.1% (β estimate –0.36, 95% CI –0.37 to –0.35, P < 0.001) and the rate of major adverse cardiovascular and cerebrovascular events (β estimate –0.24, 95% CI –0.25 to –0.23, P < 0.001) decreased from 12.7% to 10.3%. Age 70 years and older (odds ratio (OR) 2.60, 95% CI 2.57 to 2.63, P < 0.001) and cancer (OR 1.93, 95% CI 1.91 to 1.96, P < 0.001) were independent predictors of inhospital death. Conclusion Hospitalisations for heart failure increased in Germany from 2005 to 2016, whereas the major adverse cardiovascular and cerebrovascular event rate and inhospital case fatality rate decreased during this period despite higher patient age and increasing prevalence of comorbidities.

10.1177/2047487320936020https://pubmed.ncbi.nlm.nih.gov/34402877